Think Research Corporation announced that it will extend its comprehensive and freely-accessible coronavirus (COVID-19) virtual education program for healthcare professionals for another year.
The company said that this will provide clinicians in Canada and abroad with up-to-date and best-in-class clinical and treatment information to support them in treating and managing COVID-19 as the pandemic enters its third year.
Among these offerings is a unique video series entitled Straight Talk on COVID-19, created by MDBriefCase, a member of the Think Research family of companies. Launched in February 2021 and with new episodes released monthly, it has emerged as a leading resource for the company’s global membership, having received over 28,000 views to date, the company said.
READ: Think Research attests to vendor verification for VirtualCare software in Ontario
“When MDBriefCase approached us with the concept for Straight Talk, we immediately recognized its value,” said David Strain, clinical lead for the COVID-19 Service in South-West England and clinical senior lecturer at the University of Exeter Medical School. “With information changing so quickly, clinicians have been left trying to decipher messages that often conflict.”
He added: “We’ve approached the series as an opportunity to not only share our own perspectives but to clarify current evidence and strategies in a way that clinicians can immediately apply the information within their practice.”
The Straight Talk series is hosted by Strain along with internationally recognized experts Peter Lin, a family physician and director of primary care initiatives at the Canadian Heart Research Centre, and Michael Boivin, a clinical pharmacist consultant.
Each episode features a candid, unfiltered discussion on current COVID-19 data, trends, research, and recommendations, responding to the most urgent questions and challenges facing HCPs. Topics have included vaccine recommendations for various patient populations, counselling vaccine-hesitant patients, current treatment options, updates on the Delta and Omicron variants, and booster/third dose recommendations, among others.
Strain added: “Being situated in England, I’ve also been able to contribute a glimpse into what Canadian clinicians should expect and prepare for. From the outset, the United Kingdom and Europe have experienced the impact of the virus and its variants somewhat ahead of North America.”
He said that sharing those insights and preparing clinicians for what may be ahead has added to the overall value of the series.
Think Research CEO Sachin Aggarwal said: “As clinical knowledge on COVID-19 continues to evolve, we are proud to be a trusted source for the most current information. Beyond being among the most up-to-date information sources available, the Straight Talk series is also appealing to clinicians because of the authenticity our three hosts bring.”
He noted that care providers can immediately internalize the very important data and recommendations being discussed. “It’s practical, accessible, and easy to watch – which, as our providers continue to feel the strain of the pandemic, is becoming increasingly important.”
Contact Ritika at ritika@proactiveinvestors.com